Phase III trial
In phase III clinical trials, a study drug or treatment is given to large groups of people (1,000 to 3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. These larger numbers are necessary to generate statistically significant results and to give the company meaningful data to present to the FDA. This testing often takes one to three years.
Recent Mentions on Fool.com
- Keep Calm and Carry On, Roche Stock
- Allergan Stock Earnings: Good Enough to Fight off Valeant?
- Can Roche Find Rare Success In Alzheimer's?
- Is This the Crown Jewel of the ISIS Pipeline?
- Why Boston Scientific Corporation, Regeneron Pharmaceuticals, Inc., and Vertex Pharmaceuticals Incor
- 3 Undervalued Amgen Growth Opportunities to Watch